Purple Biotech (PPBT) Other Gross PP&E Adjustments (2015 - 2026)
Purple Biotech (PPBT) reported Other Gross PP&E Adjustments of -$161000.0 for Q1 2026, up 27.48% on a QoQ basis from -$222000.0 in Q4 2025.
Purple Biotech (PPBT) has 2 years of Other Gross PP&E Adjustments data on file, last reported at -$161000.0 in Q1 2026.
- Quarterly Other Gross PP&E Adjustments changed N/A year-over-year to -$161000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$161000.0 (changed N/A YoY) and the FY2025 annual result came in at -$222000.0, changed N/A from the prior year.
- Other Gross PP&E Adjustments climbed to -$161000.0 in Q1 2026 per PPBT's latest filing, from -$222000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$161000.0 in Q1 2026 and bottomed at -$222000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | -161,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -161,000.00 |
| Mar 31, 2026 | -161,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Sep 30, 2025 | -323,000.00 |
| Sep 30, 2025 | -323,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Mar 31, 2025 | -126,000.00 |
| Mar 31, 2025 | -126,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Sep 30, 2024 | -202,000.00 |
| Sep 30, 2024 | -202,000.00 |
| Jun 30, 2024 | -240,000.00 |
| Jun 30, 2024 | -240,000.00 |
| Mar 31, 2024 | -278,000.00 |
| Mar 31, 2024 | -278,000.00 |
| Dec 31, 2023 | -316,000.00 |
| Dec 31, 2023 | -316,000.00 |
| Sep 30, 2023 | -354,000.00 |
| Sep 30, 2023 | -354,000.00 |
| Jun 30, 2023 | -392,000.00 |
| Jun 30, 2023 | -392,000.00 |
| Mar 31, 2023 | -430,000.00 |
| Mar 31, 2023 | -430,000.00 |
| Dec 31, 2022 | -467,000.00 |
| Dec 31, 2022 | -467,000.00 |
| Sep 30, 2022 | -505,000.00 |
| Sep 30, 2022 | -505,000.00 |
| Jun 30, 2022 | -543,000.00 |
| Jun 30, 2022 | -543,000.00 |
| Mar 31, 2022 | -581,000.00 |
| Mar 31, 2022 | -581,000.00 |
| Dec 31, 2021 | -619,000.00 |
| Dec 31, 2021 | -619,000.00 |
| Sep 30, 2021 | -658,000.00 |
| Sep 30, 2021 | -658,000.00 |
| Jun 30, 2021 | -708,000.00 |
| Jun 30, 2021 | -708,000.00 |
| Mar 31, 2021 | -752,000.00 |
| Mar 31, 2021 | -752,000.00 |
| Dec 31, 2020 | -790,000.00 |
| Dec 31, 2020 | -790,000.00 |
| Jun 30, 2020 | -108,000.00 |
| Jun 30, 2020 | -108,000.00 |
| Dec 31, 2019 | -206,000.00 |
| Dec 31, 2019 | -206,000.00 |
| Jun 30, 2019 | -311,000.00 |
| Jun 30, 2019 | -311,000.00 |
| Sep 30, 2015 | 6,000.00 |
| Sep 30, 2015 | 6,000.00 |